Key result
Medicare 2024 specifications define adequate BP control for hypertensive patients as under 140/90 mmHg.
Why the study?
Optimal HTN control reduces cardiovascular risk, but standardized management and control needed improvement through process improvement cycles in an academic outpatient primary care setting.
Does Home Blood Pressure Monitoring with timely follow-up improve BP control in Medicare patients with uncontrolled hypertension?
Does Home Blood Pressure Monitoring with timely follow-up improve BP control in Medicare patients with uncontrolled hypertension?
A quality improvement project demonstrated that home blood pressure monitoring combined with timely follow-up effectively improves hypertension control in Medicare patients.
Home BP monitoring with timely follow-up improves HTN control in Medicare primary care patients; extends quality improvement evidence for guideline implementation.
Objectives: Optimal hypertension (HTN) control is critical for reducing cardiovascular risk. National quality measures and clinical guidelines for HTN define the most recent BP reading of ≥140/90 mmHg during the performance year as uncontrolled. In the current study, we aim to improve and standardize HTN management and control through process improvement cycles in an Academic outpatient primary care setting. Methods: Using our outpatient database, we first identified a sample of Medicare beneficiaries with HTN determined to be uncontrolled during performance years 2023 and 2024, and performing root-case analyses to find any contributing factors, and develop a strategy for improving HTN control and quality metrics. Results: A lack of repeat BP measurement and inadequate follow-up were found to be the major factors contributing to uncontrolled BP. Home Blood Pressure Monitoring (HBPM) with timely follow-up was tested as a potential opportunity for improving HTN quality metrics in these patients. Device validation showed that 40 of 42 home BP monitors provided accurate readings. Subsequently, 38 BP uncontrolled patients were engaged through home or office BP assessments. After 2 weeks, 25 of 38 (66%) patients achieved Medicare-defined BP controlled, including 10 through HBPM alone, 8 with follow up during an office visit. Thirteen patients were still BP uncontrolled with a relative risk (RR) of 0.34 (95% CI: 0.22-0.52, P < .001). Conclusion: These results support HBPM together with close follow-up as an effective approach to reduce the risk of uncontrolled hypertension and associated noncompliance in value-based care reporting.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied Essential hypertension. Quality ID #236: Controlling High Blood Pressure was evaluated on Percentage of patients whose most recent blood pressure was adequately controlled (< 140/90 mmHg) during the measurement period. This document outlines the 2024 Medicare Part B Claims specifications for Quality ID #236, which measures the percentage of patients aged 18-85 with hypertension whose blood pressure is adequately controlled (<140/90 mmHg).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: